Financials Q-linea AB

Equities

QLINEA

SE0011527845

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 12:00:00 2024-07-05 pm EDT 5-day change 1st Jan Change
3.985 SEK -1.97% Intraday chart for Q-linea AB -3.04% +7.70%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,317 4,592 3,301 306.7 432.3 465.6 - -
Enterprise Value (EV) 1 990.4 4,261 2,953 233.8 350.4 529.3 470.8 465.6
P/E ratio -7.43 x -19.7 x -13.8 x -1.14 x -1.06 x -3.32 x -4.86 x -9.96 x
Yield - - - - - - - -
Capitalization / Revenue 1,317 x 3,975 x 337 x 24 x 97.4 x 17.9 x 2.88 x 3.42 x
EV / Revenue 990 x 3,689 x 302 x 18.3 x 78.9 x 20.4 x 2.91 x 3.42 x
EV / EBITDA -5.66 x -19.8 x -13.1 x -0.95 x -1.64 x -3.48 x -3.48 x -6.05 x
EV / FCF -5.58 x -17 x -10.6 x - -1.48 x -3.48 x -6.11 x -6.21 x
FCF Yield -17.9% -5.88% -9.44% - -67.4% -28.7% -16.4% -16.1%
Price to Book 3.86 x 12.1 x 7.66 x 1.88 x 2.28 x 2.03 x 4.33 x -
Nbr of stocks (in thousands) 22,907 27,009 29,209 29,209 116,838 116,838 - -
Reference price 2 57.50 170.0 113.0 10.50 3.700 3.985 3.985 3.985
Announcement Date 2/13/20 2/18/21 2/17/22 2/16/23 2/27/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1 1.155 9.785 12.79 4.44 26 161.8 136
EBITDA 1 -175 -215.4 -226.2 -247 -213.1 -152 -135.2 -77
EBIT 1 -179.1 -221.5 -233.6 -262.2 -230.6 -172 -153.2 -100
Operating Margin -17,910% -19,181.21% -2,386.82% -2,050.73% -5,193.4% -661.54% -94.69% -73.53%
Earnings before Tax (EBT) 1 -177.4 -218.7 -231.2 -268.7 -229.4 -178 -152.9 -98
Net income 1 -177.4 -218.7 -231.2 -268.7 -229.4 -178 -152.9 -90
Net margin -17,740% -18,931.17% -2,363.23% -2,101.14% -5,165.9% -684.62% -94.46% -66.18%
EPS 2 -7.740 -8.640 -8.190 -9.200 -3.480 -1.200 -0.8200 -0.4000
Free Cash Flow 1 -177.4 -250.5 -278.9 - -236.3 -152 -77 -75
FCF margin -17,739.2% -21,691.17% -2,849.96% - -5,321.78% -584.62% -47.58% -55.15%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 2/13/20 2/18/21 2/17/22 2/16/23 2/27/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 0.022 1.358 2.998 0.061 1.476 3 7 12
EBITDA 1 -58.04 -60.11 -43.83 -51.06 -51.1 -38 -33 -31
EBIT 1 -62.24 -64.61 -48.25 -55.45 -55.91 -43 -38 -36
Operating Margin -282,927.27% -4,757.51% -1,609.51% -90,900% -3,787.87% -1,433.33% -542.86% -300%
Earnings before Tax (EBT) - - - - - - - -
Net income - - - - - - - -
Net margin - - - - - - - -
EPS 2 - - -0.5600 -0.8200 - -0.4000 -0.3000 -0.2000
Dividend per Share - - - - - - - -
Announcement Date 5/4/23 7/13/23 11/2/23 2/27/24 5/30/24 - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - 63.7 5.24 -
Net Cash position 1 327 331 348 72.9 81.9 - - -
Leverage (Debt/EBITDA) - - - - - -0.4191 x -0.0387 x -
Free Cash Flow 1 -177 -251 -279 - -236 -152 -77 -75
ROE (net income / shareholders' equity) -41.5% -60.6% -57% -90.5% -130% -91% -86.1% -247%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 14.90 14.10 14.80 5.590 1.620 1.960 0.9200 -
Cash Flow per Share - - - - - - - -
Capex 1 7.63 13.2 12 17.2 7.77 10 16.4 14
Capex / Sales 763.2% 1,145.28% 122.34% 134.88% 174.91% 38.46% 10.16% 10.29%
Announcement Date 2/13/20 2/18/21 2/17/22 2/16/23 2/27/24 - - -
1SEK in Million2SEK
Estimates